 |
Porfimer sodium |
|---|---|
| Trade Name | Photofrin |
| Orphan Indication | For the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1989-06-06 00:00:00 |
| Sponsor | QLT Phototherapeutics, Inc.;Lederle Laboratories, 401 North Middletown Road;Pearl River, New York, 10965 |
